I overensstemmelse med virkningsmekanismen reducerede rosiglitazon insulinresistens og forbedrede pankreatisk β- celle funktion. ###>28 Consistent with the mechanism of action, rosiglitazone reduced insulin resistance and improved pancreatic ß-cell function.